Home » Topics » BioWorld Science

BioWorld Science
RSS

Fast track status for INO-1001 for patients with STEMI

July 2, 2004

FDA accepts IND for MN-029

July 2, 2004

NX-1207 shows potential as a front-line treatment for BPH in phase I/II trials

July 2, 2004

Priority review and accelerated approval designations for Antegren BLA

July 2, 2004

Aplidin receives orphan drug status for ALL

July 2, 2004

Phase II study of GDNF for Parkinson's fails to meet primary endpoint

July 2, 2004

Effective cytolysis of Hodgkin's lymphoma tumor cells by antibody-cytokine fusion protein

July 2, 2004

Preclinical evidence for the effects of rimonabant on body weight and food intake

July 1, 2004

The efficacy of vardenafil in ED is not affected by glycemic control or diabetes

July 1, 2004

Japanese launch for Serevent 50 Diskus

July 1, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...